*These authors contributed equally to the preparation of this manuscript. Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, ...
BOSTON--(BUSINESS WIRE)--Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback